NWPF

News ArchivesRead News

Smell Test Plus Imaging May Spot Parkinson's Early

Wednesday June 18, 2014

Megan Brooks

Medscape Medical News - Olfactory testing coupled with dopamine transporter (DAT) imaging can help identify people likely to develop clinical signs of Parkinson's disease (PD), a new study hints.

Among a cohort of hyposomic adults with DAT deficit, 61% developed PD after 4 years.

"That's pretty amazing," Danna Jennings, MD, from the Institute for Neurodegenerative Disorders, New Haven, Connecticut, told Medscape Medical News.

"Everybody with Parkinson's ultimately has a decrease in their sense of smell," Dr. Jennings said. "It's one of the very first symptoms, but not everyone who has a decrease in their sense of smell goes on to develop Parkinson's because there are many different causes for hyposmia. That's where the imaging comes in."

She presented the study at the recent International Parkinson and Movement Disorder Society (MDS) 18th International Congress of Parkinson's Disease and Movement Disorders.

PARS Study

She and her colleagues at the University of Pennsylvania in Philadelphia developed the Parkinson Associated Risk Syndrome (PARS) study to see whether they could combine olfactory testing with imaging to detect PD before clinical signs appear.

"PARS is a study utilizing a 2-tiered approach to identify hyposmic individuals with a DAT deficit and therefore at increased risk for PD," Dr. Jennings explained.

The PARS cohort includes 303 participants (203 hyposmic and 100 normosmic). The participants completed a baseline evaluation and returned for annual clinical and 123I-β-CIT/single-photon emission computed tomography at 2 and 4 years. Not all participants have completed all assessments.

At baseline, 23 (11%) of 203 hyposmic participants without PD at baseline had a severe DAT deficit (<65% of age-expected striatal binding ratio). Eight of these participants (35%) phenoconverted to PD at 2 years and 14 (61%) phenoconverted at 4 years.

An additional 14 hyposmic participants had a severe DAT deficit on imaging at year 2 or year 4, and 3 of those have phenoconverted so far, Dr. Jennings reported.

Clinical characteristics of hyposmic participants reveal that those scoring at or below the 10th percentile for age and sex on the University of Pennsylvania Smell Identification Test (UPSIT) and have a DAT deficit are more likely to phenoconvert to PD within 4 years.

Implications for Prevention Trials

"These data suggest that the PARS strategy of combining sequential assessment of olfaction and DAT imaging can enrich a population for phenoconversion within 4 years," Dr. Jennings told Medscape Medical News.

"While this strategy remains limited to research applications, it does provide a scalable mechanism to identify individuals within the general population that may be at risk for PD and would be eligible for treatment trials evaluating medications with neuro-preventative potential," she added.

"That's the critical piece. It's always been thought that we are testing these types of agents too late in the game, after there is too much pathology in the brain. So identifying people early will help to potentially make a bigger impact on this disease," Dr. Jennings said.

In a statement about these results from the Movement Disorder Society, Anthony Lang, MD, director of the Movement Disorders Clinic at Toronto Western Hospital in Canada, said, "The knowledge that comes from this study will have important implications to the recruitment of individuals for future neuroprotective trials that will hopefully have a greater chance of success than previous efforts that exclusively involved patients whose disease had already evolved to the stage of manifesting the clinical features of Parkinson's disease."

The US Department of Defense supported this study.

Brooks, Megan. (19 June 2014). Medscape Medical News. Smell Test Plus Imaging May Spot Parkinson's Early. http://www.medscape.com/viewarticle/826992?src=rss

Recent News

Jul 18 - Doctors Unravel The Placebo Effect Of Fake Parkinson's Disease Treatment
Jul 15 - Parkinson's Boosts Creativity: Study
Jul 15 - How A Single Protein Could Unlock New Treatments For Brain Cancer And Parkinson's Disease
Jul 10 - Imaging Biomarker Proposed for Parkinson’s Disease
Jul 10 - Sleep Disturbances, Common in Parkinson's Disease, can be Early Indicator of Disease Onset
Jul 9 - Cinnamon May be Used to Halt the Progression of Parkinson's Disease
Jul 8 - Stanford Doctors Treat Parkinson's Disease Patients with Life-Changing Technology
Jul 7 - MRI Brain Scans Detect People with Early Parkinson's
Jul 3 - Low Accuracy of Clinical Diagnosis for Early Parkinson’s Disease
Jul 2 - Walking Improves Mood, Eases Fatigue in Those with Parkinson's Disease
Jun 27 - Northwest Parkinson's Foundation Leaves Cure to Others, Focuses on Today
Jun 26 - New Insights Could Help in Battle to Beat Parkinson's Disease
Jun 26 - More Benefits Found In Deep Brain Stimulation for Parkinson’s
Jun 24 - Using Femtosecond Lasers to Administer Drugs
Jun 18 - Bee-Venom Acupuncture Shows Promise in Parkinson's
Jun 18 - Smell Test Plus Imaging May Spot Parkinson's Early
Jun 17 - Magnetic Stimulation Improves Parkinson's Symptoms
Jun 11 - Parkinson's Disease Early Stages Detected With 'Simple' MRI; Up To 85% Accurate
Jun 11 - Fetal-cell Revival for Parkinson’s
Jun 11 - Meet the 11-year-old Girl who Invented an Un-spillable, Un-breakable Cup for her Grandfather with Parkinson's Disease